Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Inv. presentation
MERRIMACK PHARMACEUTICALS INC (MACK) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/04/2022 SC 13G Point72 Asset Management, L.P. reports a 6.7% stake in Merrimack Pharmaceuticals, Inc.
02/14/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/12/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/14/2019 SC 13G Newtyn Management, LLC reports a 6.7% stake in Merrimack pharmaceuticals INC.
02/08/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
04/10/2018 SC 13G BIOTECHNOLOGY VALUE FUND L P reports a 8.3% stake in Merrimack Pharmaceuticals, Inc.
01/25/2018 SC 13G BlackRock Inc. reports a 6.1% stake in MERRIMACK PHARMACEUTICALS INC
02/14/2017 SC 13G Consonance Capital Management LP reports a 7% stake in Merrimack Pharmaceuticals, Inc.
02/10/2016 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
02/10/2016 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
04/10/2012 SC 13G MERRIMACK PHARMACEUTICALS INC reports a 10.6% stake in MERRIMACK PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy